The Latest Cardiac and Vascular News
Findings suggest that monitoring changes in stroke volume and cardiac output could help predict mortality in critically ill patients Baxter-sponsored symposium advances expert dialogue on fluid management DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a leader in patient monitoring, physical assessment and vision screening products, announced the findings of an observational […]
— Led by director of Penn Cardiovascular Institute (Penn CVI), CHOP CVI combines the best of CHOP and Penn Medicine to drive scientific discovery– PHILADELPHIA, April 18, 2022 /PRNewswire/ — Deepening its commitment to pediatric cardiovascular research, the Children’s Hospital of Philadelphia (CHOP) Research Institute has launched the CHOP Cardiovascular Institute (CHOP CVI). Led by Daniel […]
CareDx Testing Services Have Been Used in Over 30,000 Heart Transplant Patients and Over 90 Percent of Centers in the United States SOUTH SAN FRANCISCO, Calif., April 14, 2022 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, […]
DEDUCE study demonstrates AUC of 0.86 in overall cohort, including more than 700 prospective samples AUSTIN, Texas, April 13, 2022 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that its clinical validation study1 on its donor-derived cell-free DNA (dd-cfDNA) test for the assessment of acute rejection in heart transplant patients, […]
Analysis of pooled Phase 3 data demonstrated 26.5% reduction vs. placebo in LDL-C from bempedoic acid monotherapy and 39.2% reduction vs. placebo in LDL-C from bempedoic acid and ezetimibe fixed-dose combination in patients not taking statins ANN ARBOR, Mich., April 13, 2022 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced […]
Intuitive monitor featuring patient-tailored approach is now in clinical use in select centers in U.S. and Europe LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today announced receipt of regulatory approvals and the start of a targeted commercial launch for the Essenz™ Patient Monitor. The transformative monitoring […]
Novel multi-protein blood test data on 450 patients presented at 2022 American College of Cardiology Scientific Sessions KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc. today announces the presentation of patient data demonstrating its Artificial Intelligence (AI)-driven HART CVE blood test is highly accurate in determining whether a person with diabetes will have a heart attack […]
HANGZHOU, China, April 11, 2022 /PRNewswire/ — On April 8th, 2022, VenusP-ValveTM, Venus Medtech’s in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, received CE marking under the Medical Devices Regulation (MDR) to be marketed in Europe. Designed to treat patients with moderate to severe pulmonary regurgitation with or without right ventricular outflow tract […]
Anticipates Q4 2022 commercial launch, if approved BURLINGTON, Mass., April 11, 2022 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that the […]
The company plans to develop Lilly’s first-in-class clinical stage anti-angiopoietin-like 3/8 monoclonal antibody for treatment of atherosclerotic cardiovascular disease and potentially other conditions OXFORD, England & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Kyttaro announces that it has entered into an agreement for the worldwide exclusive license of an anti-angiopoietin-like (ANGPTL) 3/8 monoclonal antibody program […]
